Hong Kong tips off Vietnam about contaminated GSK drug

Just days after ordering one importer to suspend sales of a drug and another to withdraw a drug from the market, Vietnamese officials now seek samples of the GlaxoSmithKline ($GSK) pediatric antibiotic Augmentin for precautionary testing. The Drug Administration of Vietnam has asked GSK to collect samples for testing following discovery of a plasticizer in Augmentin products distributed in Hong Kong.

Testing will focus on the levels of diisodecyl phthalate (DIDP), di-ethylhexyl phthalates, and other derivatives. In Hong Kong, officials said they detected DIDP in Augmentin tablets at a level twice as high as Europe's limit for the chemical in food contact materials.

Last month, plasticizer detected in a pediatric antibiotic manufactured by GSK in France led to a government-ordered recall by the drug giant.

The Vietnamese product test results are expected by August 5, 2011.

- read the story
- here's more

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.